CymaBay Therapeutics, Inc. 4
4 · CymaBay Therapeutics, Inc. · Filed Jan 28, 2016
Insider Transaction Report
Form 4
Van Wart Harold
DirectorPresident and CEO
Transactions
- Award
Employee Stock Option (right to buy)
2016-01-26+157,500→ 157,500 totalExercise: $1.06Exp: 2026-01-25→ Common Stock (157,500 underlying)
Footnotes (1)
- [F1]The option vests with respect to one-quarter of the underlying shares upon the first anniversary of the grant date, and then with respect to the remaining shares monthly thereafter over the next three years.